| Primary |
|
|
| Secondary |
| Product Used For Unknown Indication |
39.0% |
| Ill-defined Disorder |
12.2% |
| Drug Use For Unknown Indication |
11.5% |
| Pyrexia |
6.6% |
| Infection |
5.5% |
| Pneumonia |
4.9% |
| Constipation |
4.4% |
| Hypertension |
2.5% |
| Infection Prophylaxis |
2.5% |
| Sepsis |
1.9% |
| Fluid Replacement |
1.7% |
| Pain |
1.1% |
| Back Pain |
0.9% |
| Bacteraemia |
0.9% |
| Dysuria |
0.9% |
| Pneumonia Mycoplasmal |
0.9% |
| Fungal Infection |
0.8% |
| Acute Myeloid Leukaemia |
0.6% |
| Allogenic Bone Marrow Transplantation Therapy |
0.6% |
| Bacterial Infection |
0.6% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
33.3% |
| Interstitial Lung Disease |
8.6% |
| Toxic Epidermal Necrolysis |
8.6% |
| Nausea |
7.4% |
| Lymphocyte Stimulation Test Positive |
4.9% |
| Liver Disorder |
3.7% |
| Renal Failure Acute |
3.7% |
| Stomatitis |
3.7% |
| Drug Eruption |
2.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.5% |
| Nikolsky's Sign |
2.5% |
| Pancytopenia |
2.5% |
| Rash Maculo-papular |
2.5% |
| Serum Ferritin Increased |
2.5% |
| Skin Exfoliation |
2.5% |
| Thrombocytopenia |
2.5% |
| Urticaria |
2.5% |
| Acute Generalised Exanthematous Pustulosis |
1.2% |
| Agranulocytosis |
1.2% |
| Aphasia |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Prophylaxis |
14.9% |
| Infection Prophylaxis |
11.7% |
| Drug Use For Unknown Indication |
10.3% |
| Bone Marrow Conditioning Regimen |
7.5% |
| Prophylaxis Against Graft Versus Host Disease |
6.3% |
| Premedication |
2.8% |
| Ewing's Sarcoma Recurrent |
2.1% |
| Postoperative Fever |
2.1% |
| Pneumonia |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Infection |
1.7% |
| Antifungal Prophylaxis |
1.5% |
| Acute Lymphocytic Leukaemia |
1.4% |
| Mantle Cell Lymphoma |
1.4% |
| Multiple Myeloma |
1.4% |
| Renal Transplant |
1.2% |
| Head And Neck Cancer |
1.1% |
| Constipation |
1.0% |
| Immunosuppression |
1.0% |
|
| White Blood Cell Count Decreased |
12.1% |
| Thrombocytopenia |
9.1% |
| Pneumonia |
8.3% |
| Renal Failure Acute |
6.1% |
| Renal Impairment |
6.1% |
| Pyrexia |
5.3% |
| Thrombotic Microangiopathy |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
| Hypoxia |
4.5% |
| Rhabdomyolysis |
4.5% |
| Hypoglycaemia |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Respiratory Failure |
3.8% |
| Urinary Retention |
3.8% |
| Bronchopulmonary Aspergillosis |
3.0% |
| Drug Withdrawal Syndrome Neonatal |
3.0% |
| Haemorrhage |
3.0% |
| Infection |
3.0% |
| Pneumothorax |
3.0% |
| Sepsis |
3.0% |
|
| Interacting |
| Pneumonia |
50.0% |
| Ventricular Tachycardia |
50.0% |
|
|
